SemperVirens Venture Capital

SemperVirens operates an ecosystem-driven model that integrates more than 8,000 enterprise buyers, 200 executive advisors, and 50 sector experts into its investment platform. The firm uses this network to generate warm introductions to potential customers and distribution partners, claiming over 5,000 customer introductions for its portfolio. It also runs an accelerator program for early-stage companies, with cohorts recruited via public calls on its website.

The firm deploys across early-stage and growth rounds through two distinct investment vehicles. Its accelerator program captures companies at the earliest phases, while its growth funds support more mature startups. SemperVirens states it provides stage-specific capital with a long-term partnership lens, helping companies progress from first customers to meaningful ARR.

SemperVirens invests in AI-driven platforms across healthcare, workforce productivity, and financial resilience. Its disclosed portfolio includes companies in digital health for women (Midi Health), global payroll and employment infrastructure (Remote), mental health access (Rula), and small-business retirement plans (Human Interest).

The firm has raised over $300 million from institutional, strategic, and impact-oriented limited partners, according to its website. It does not publicly name its individual LPs, but the mix reflects a capital base spanning traditional institutional allocators, corporate strategics, and impact investors.

SemperVirens uses two separate investment vehicles to fund companies at different stages, suggesting a commitment-based fund structure rather than a series of independent direct deals. The firm describes its capital as selective and stage-specific, deployed through long-term partnerships rather than opportunistic co-investments.